Target
Tyrosine-protein kinase Lck
Ligand
BDBM50120116
Substrate
n/a
Meas. Tech.
ChEBML_96910
IC50
1.7±n/a nM
Citation
 Chen, PIwanowicz, EJNorris, DGu, HHLin, JMoquin, RVDas, JWityak, JSpergel, SHde Fex, HPang, SPitt, SShen, DRSchieven, GLBarrish, JC Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potency. Bioorg Med Chem Lett 12:3153-6 (2002) [PubMed]  Article 
Target
Name:
Tyrosine-protein kinase Lck
Synonyms:
2.7.10.2 | LCK | LCK_HUMAN | LSK | Leukocyte C-terminal Src kinase | Lymphocyte cell-specific protein-tyrosine kinase | Lymphocyte-specific protein tyrosine kinase | P56-LCK | Protein YT16 | Proto-oncogene Lck | Proto-oncogene tyrosine-protein kinase LCK | Src/Lck kinase | T cell-specific protein-tyrosine kinase
Type:
n/a
Mol. Mass.:
57987.83
Organism:
Homo sapiens (Human)
Description:
P06239
Residue:
509
Sequence:
MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP
  
Inhibitor
Name:
BDBM50120116
Synonyms:
CHEMBL108362 | N*4*-(2-Chloro-6-methyl-phenyl)-N*7*-(2-dimethylamino-ethyl)-8-methoxy-imidazo[1,5-a]quinoxaline-4,7-diamine | N4-(2-chloro-6-methylphenyl)-N7-(2-(dimethylamino)ethyl)-8-methoxyimidazo[1,5-a]quinoxaline-4,7-diamine
Type:
Small organic molecule
Emp. Form.:
C22H25ClN6O
Mol. Mass.:
424.927
SMILES:
COc1cc2c(cc1NCCN(C)C)nc(Nc1c(C)cccc1Cl)c1cncn21
Structure:
Search PDB for entries with ligand similarity: